Study Questions Real-World Benefit of Breakthrough Alzheimer's Drugs
A new scientific report has cast doubt on how effectively Leqembi and Kisunla — recently approved Alzheimer's treatments hailed as breakthroughs — actually slow disease progression. The findings complicate the narrative around the first new Alzheimer's drugs to reach market in years.
Advertisement: Article Inline